Bloomberg Law
Dec. 11, 2020, 11:01 AMUpdated: Dec. 11, 2020, 8:23 PM

Risk of PFAS Sabotaging Covid Vaccines’ Promise Spurs Study (1)

Pat Rizzuto
Pat Rizzuto

The FDA’s anticipated approval of the first coronavirus vaccine enables scientists to kick off studies examining whether “forever chemicals” hinder the effectiveness of Covid-19 vaccines.

But studies set to go when vaccines reach their local communities aren’t big enough to shed light on what the Centers for Disease Control and Prevention has already said is an important question facing communities: how exposure to per- and polyfluoroalkyl substances may affect their risk of getting infected by Covid-19.

The ubiquitous and persistent chemicals known as PFAS have made it from factories and products into air, and the bloodstreams of 95% of Americans. ...

Learn more about Bloomberg Law or Log In to keep reading:

Learn About Bloomberg Law

AI-powered legal analytics, workflow tools and premium legal & business news.

Already a subscriber?

Log in to keep reading or access research tools.